Browse views: by Year, by Function, by GLF, by Subfunction, by Conference, by Journal

Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo

Velcicky, Juraj and Bodendorf, Ursula and Rigollier, Pascal and Epple, Robert and Beisner, Daniel and Guerini, Danilo and Smith, Philip and Liu, Bo and Feifel, Roland and Wipfli, Peter and Aichholz, Reiner and Couttet, Philippe and Dix, Ina and Widmer, Toni and Wen, Ben and Brandl, Trixi (2018) Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo. Journal of Medicinal Chemistry, 61 (3). pp. 865-880. ISSN 0022-26231520-4804

Abstract

Signal peptide peptidase-like 2a (SPPL2a) is an aspartic intramembrane protease which has recently been shown to play an important role in the development and function of antigen presenting cells such as B lymphocytes and dendritic cells. In this paper, we describe the discovery of the first selective and orally active SPPL2a inhibitor (S)-2-cyclopropyl-N1-((S)-5,11-dioxo-10,11-dihydro-1H,3H,5H-spiro[benzo[d]pyrazolo[1,2-a][1,2]diazepine-2,1′-cyclopropan]-10-yl)-N4-(5-fluoro-2-methylpyridin-3-yl)succinamide 40 (SPL-707). This compound shows adequate selectivity against the closely related enzymes γ-secretase and SPP and a good pharmacokinetic profile in mouse and rat. Compound 40 significantly inhibited processing of the SPPL2a substrate CD74/p8 fragment in rodents at doses ≤10 mg/kg b.i.d. po. Oral dosing of 40 for 11 days at ≥10 mg/kg b.i.d. recapitulated the phenotype seen in Sppl2a knockout (ko) and ENU mutant mice (reduced number of specific B cells and myeloid dendritic cells). Thus, we believe that SPPL2a represents an interesting and druggable pharmacological target, potentially providing a novel approach for the treatment of autoimmune diseases by targeting B cells and dendritic cells.

Item Type: Article
Date Deposited: 24 Feb 2018 00:45
Last Modified: 24 Feb 2018 00:45
URI: https://oak.novartis.com/id/eprint/34024

Search

Email Alerts

Register with OAK to receive email alerts for saved searches.